Observations placeholder
Emend
Identifier
017344
Type of Spiritual Experience
Number of hallucinations: 16
Background
A description of the experience
Aprepitant (brand name: Emend (the brand name used in all English-speaking countries)) is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor.
Aprepitant is used for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) and for prevention of postoperative nausea and vomiting. It was approved by the FDA in 2003.
On January 2008, the FDA approved fosaprepitant, an intravenous form of aprepitant, which is to be sold under the tradename Emend Injection in the US and as Ivemend in some other countries
On Dec, 31, 2016 1,582 people reported to have side effects when taking Aprepitant. Among them, 1 person (0.06%) has Hallucination, Auditory
On Jan, 04, 2017 6,117 people reported to have side effects when taking Emend. Among them, 15 people (0.25%) have Hallucination
Time on Emend when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Emend :
| Female | Male | |
| Hallucination | 81.82% | 18.18% |
Age of people who have Hallucination when taking Emend :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 85.71% | 0.00% | 0.00% | 14.29% |